These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21191765)

  • 1. 6-Alkylsalicylic acid analogues inhibit in vitro ATPase activity of heat shock protein 90.
    Wu CZ; Moon AN; Choi O; Kang SY; Lee JJ; Lee D; Hwang BY; Kim YH; Lee HS; Hong YS
    Arch Pharm Res; 2010 Dec; 33(12):1997-2001. PubMed ID: 21191765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
    Kamal A; Thao L; Sensintaffar J; Zhang L; Boehm MF; Fritz LC; Burrows FJ
    Nature; 2003 Sep; 425(6956):407-10. PubMed ID: 14508491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of Hsp90.
    Le Brazidec JY; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF
    J Med Chem; 2004 Jul; 47(15):3865-73. PubMed ID: 15239664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity.
    Rowlands MG; Newbatt YM; Prodromou C; Pearl LH; Workman P; Aherne W
    Anal Biochem; 2004 Apr; 327(2):176-83. PubMed ID: 15051534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IC101 induces apoptosis by Akt dephosphorylation via an inhibition of heat shock protein 90-ATP binding activity accompanied by preventing the interaction with Akt in L1210 cells.
    Fujiwara H; Yamakuni T; Ueno M; Ishizuka M; Shinkawa T; Isobe T; Ohizumi Y
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1288-95. PubMed ID: 15161934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90.
    Le Bras G; Radanyi C; Peyrat JF; Brion JD; Alami M; Marsaud V; Stella B; Renoir JM
    J Med Chem; 2007 Nov; 50(24):6189-200. PubMed ID: 17979263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
    Gopalsamy A; Shi M; Golas J; Vogan E; Jacob J; Johnson M; Lee F; Nilakantan R; Petersen R; Svenson K; Chopra R; Tam MS; Wen Y; Ellingboe J; Arndt K; Boschelli F
    J Med Chem; 2008 Feb; 51(3):373-5. PubMed ID: 18197612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
    Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
    J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.
    Sheikha GA; Al-Sha'er MA; Taha MO
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):603-9. PubMed ID: 21190426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity.
    Avila C; Kornilayev BA; Blagg BS
    Bioorg Med Chem; 2006 Feb; 14(4):1134-42. PubMed ID: 16213144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the ATPase activity of the molecular chaperones Hsp90 and Hsp72 using the TranscreenerTM ADP assay kit.
    Rowlands M; McAndrew C; Prodromou C; Pearl L; Kalusa A; Jones K; Workman P; Aherne W
    J Biomol Screen; 2010 Mar; 15(3):279-86. PubMed ID: 20147598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 inhibitors identified from a library of novobiocin analogues.
    Yu XM; Shen G; Neckers L; Blake H; Holzbeierlein J; Cronk B; Blagg BS
    J Am Chem Soc; 2005 Sep; 127(37):12778-9. PubMed ID: 16159253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins.
    McLaughlin SH; Sobott F; Yao ZP; Zhang W; Nielsen PR; Grossmann JG; Laue ED; Robinson CV; Jackson SE
    J Mol Biol; 2006 Feb; 356(3):746-58. PubMed ID: 16403413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITZ-1, a client-selective Hsp90 inhibitor, efficiently induces heat shock factor 1 activation.
    Kimura H; Yukitake H; Tajima Y; Suzuki H; Chikatsu T; Morimoto S; Funabashi Y; Omae H; Ito T; Yoneda Y; Takizawa M
    Chem Biol; 2010 Jan; 17(1):18-27. PubMed ID: 20142037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic 6-alkylsalicylic acids from the endophytic Streptomyces laceyi.
    Kim N; Shin JC; Kim W; Hwang BY; Kim BS; Hong YS; Lee D
    J Antibiot (Tokyo); 2006 Dec; 59(12):797-800. PubMed ID: 17323647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin.
    da Rocha Dias S; Friedlos F; Light Y; Springer C; Workman P; Marais R
    Cancer Res; 2005 Dec; 65(23):10686-91. PubMed ID: 16322212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of heat shock protein 90 targeted compounds.
    Cruz IN; Zhang Y; de la Fuente M; Schatzlein A; Yang M
    Anal Biochem; 2013 Jul; 438(2):107-9. PubMed ID: 23563445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening for Hsp90 ATPase inhibitors.
    Avila C; Hadden MK; Ma Z; Kornilayev BA; Ye QZ; Blagg BS
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3005-8. PubMed ID: 16530412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.
    Bargiotti A; Musso L; Dallavalle S; Merlini L; Gallo G; Ciacci A; Giannini G; Cabri W; Penco S; Vesci L; Castorina M; Milazzo FM; Cervoni ML; Barbarino M; Pisano C; Giommarelli C; Zuco V; De Cesare M; Zunino F
    Eur J Med Chem; 2012 Jul; 53():64-75. PubMed ID: 22538015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity.
    Kasibhatla SR; Hong K; Biamonte MA; Busch DJ; Karjian PL; Sensintaffar JL; Kamal A; Lough RE; Brekken J; Lundgren K; Grecko R; Timony GA; Ran Y; Mansfield R; Fritz LC; Ulm E; Burrows FJ; Boehm MF
    J Med Chem; 2007 Jun; 50(12):2767-78. PubMed ID: 17488003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.